Delivery Order SPE2DB22D2211-SPE2DB25FSAMD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, valued at $2,151.96. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,460.00 with firm fixed pricing and an ultimate completion date of July 24, 2025. The pharmaceutical products will be performed and delivered from the contractor's corporate office location in Conshohocken,...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 23, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,575.24 with a firm fixed price structure and an ultimate completion date of June 24, 2025. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- On July 21, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,268.75 to AmerisourceBergen Drug Corp for 1,000 tablets of Doxycycline Hyclate 100 mg. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 22, 2025. The contractor, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Doxycycline 50 mg tablets in quantities of 60 units, with a ceiling value of $47,967.46. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in a quantity of 1,000 units, valued at $1,565.14. This contract utilizes firm fixed pricing and carries an ultimate completion date of July 11, 2025. The award represents a non-set-aside, competitively awarded delivery order with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (1,000 count) on July 15, 2025, with a ceiling value of $1,299.23 and ultimate completion by July 16, 2025. This firm fixed-price delivery order represents a small-value pharmaceutical transaction within the federal medical supply chain. The contract is not designated as a set-aside procurement and will be performed at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline 50 mg tablets (60-count) with a ceiling value of $7,399.24 under a firm fixed-price contract type. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, is the location of performance for this pharmaceutical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSAMDDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 9, 2025, for the supply of Doxycycline Hydrochloride 200 mg tablets in a 60-count package. This firm fixed-price delivery order, valued at $9,367.44, is scheduled for completion by July 10, 2025, and represents a non-set-aside competitive award. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's medical supply chain, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems globally. The IDC vehicle enables the company to fulfill federal procurement needs for medications across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. Doxycycline, a broad-spectrum antibiotic, represents a critical pharmaceutical commodity for military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 7/9/25 |